← Leaderboards
Jindrich N. Kopecek
Utah State Higher Education System--University Of Utah
$15,322,903
Attributed
$15,397,055
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$15,397,055 · 14
By mechanism
R01$14,117,778 · 10
R42$995,235 · 1
R41$148,304 · 1
R03$135,738 · 2
Top collaborators
- Darwin Leroy Cheney1 shared
Others in their field
Top investigators on “Copolymer”
- Timothy P Lodge · Gordon Research Conferences$39,738,670
- Arjun G Yodh · University Of Pennsylvania$21,669,000
- Nai Phuan Ong · Princeton University$20,100,000
- Padma Gopalan · University Of Wisconsin-Madison$16,483,097
- Alexander V Kabanov · University Of Nebraska Medical Center$16,329,585
- Glenn H Fredrickson · University Of California-Santa Barbara$12,102,785
Research focus
CopolymerDrug Delivery SystemsDesignPharmaceutical PreparationsStructureBaseEvaluationIn VitroVertebral ColumnIn VivoMethacrylamideDoxorubicinMolecular WeightApoptosisMacromoleculePeptidesTumorPolymersReceptorInduction Of ApoptosisMediatingBinding (Molecular Function)S LymphomaNovel Therapeutics
Grant awards (59)
Drug-Free Macromolecular Therapeutics$331,402
R01 · FY2024 · CA · contact PI
Drug-Free Macromolecular Therapeutics$348,844
R01 · FY2023 · CA · contact PI
Drug-Free Macromolecular Therapeutics$341,867
R01 · FY2022 · CA · contact PI
Drug-Free Macromolecular Therapeutics$348,844
R01 · FY2021 · CA · contact PI
Drug-Free Macromolecular Therapeutics$348,844
R01 · FY2020 · CA · contact PI
Drug-Free Macromolecular Therapeutics$298,000
R01 · FY2018 · GM · contact PI
Drug-Free Macromolecular Therapeutics$298,000
R01 · FY2017 · GM · contact PI
Drug-Free Macromolecular Therapeutics$298,000
R01 · FY2016 · GM · contact PI
Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer$492,378
R42 · FY2015 · CA · contact PI
Drug-Free Macromolecular Therapeutics$298,000
R01 · FY2015 · GM · contact PI
Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer$502,857
R42 · FY2014 · CA · contact PI
Coiled-coil Based Drug-Free Macromolecular Therapeutics$283,100
R01 · FY2014 · GM · contact PI
Coiled-coil Based Drug-Free Macromolecular Therapeutics$273,344
R01 · FY2013 · GM · contact PI
DOUBLE-TARGETED MACROMOLECULAR THERAPEUTICS FOR THE TREATMENT OF PROSTATE CANCER$302,919
R01 · FY2012 · CA · contact PI
Coiled-coil Based Drug-Free Macromolecular Therapeutics$284,050
R01 · FY2012 · GM · contact PI
DOUBLE-TARGETED MACROMOLECULAR THERAPEUTICS FOR THE TREATMENT OF PROSTATE CANCER$302,919
R01 · FY2011 · CA · contact PI
BONE TARGETED DELIVERY OF ANABOLIC AGENTS$295,010
R01 · FY2011 · GM · contact PI
Coiled-coil Based Drug-Free Macromolecular Therapeutics$284,050
R01 · FY2011 · GM · contact PI
Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer$148,304
R41 · FY2011 · CA · contact PI
DOUBLE-TARGETED MACROMOLECULAR THERAPEUTICS FOR THE TREATMENT OF PROSTATE CANCER$312,288
R01 · FY2010 · CA · contact PI
BONE TARGETED DELIVERY OF ANABOLIC AGENTS$297,990
R01 · FY2010 · GM · contact PI
A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY$236,153
R01 · FY2010 · CA · contact PI
DOUBLE-TARGETED MACROMOLECULAR THERAPEUTICS FOR THE TREATMENT OF PROSTATE CANCER$312,288
R01 · FY2009 · CA · contact PI
BONE TARGETED DELIVERY OF ANABOLIC AGENTS$301,000
R01 · FY2009 · GM · contact PI
A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY$236,153
R01 · FY2009 · CA · contact PI
DOUBLE-TARGETED MACROMOLECULAR THERAPEUTICS FOR THE TREATMENT OF PROSTATE CANCER$311,769
R01 · FY2008 · CA · contact PI
BONE TARGETED DELIVERY OF ANABOLIC AGENTS$301,000
R01 · FY2008 · GM · contact PI
HYBRID HYDROGELS SELF-ASSEMBLED FROM GRAFT COPOLYMERS$281,310
R01 · FY2008 · EB · contact PI
A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY$236,153
R01 · FY2008 · CA · contact PI
HYBRID HYDROGELS SELF-ASSEMBLED FROM GRAFT COPOLYMERS$287,050
R01 · FY2007 · EB · contact PI
BONE TARGETED DELIVERY OF ANABOLIC AGENTS$269,331
R01 · FY2007 · GM · contact PI
A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY$236,153
R01 · FY2007 · CA · contact PI
IMMUNOCHEMOTHERAPY FOR OVARIAN CANCER$37,928
R03 · FY2007 · TW · contact PI
HYBRID HYDROGELS SELF-ASSEMBLED FROM GRAFT COPOLYMERS$295,623
R01 · FY2006 · EB · contact PI
BONE TARGETED DELIVERY OF ANABOLIC AGENTS$277,375
R01 · FY2006 · GM · contact PI
A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY$243,207
R01 · FY2006 · CA · contact PI
IMMUNOCHEMOTHERAPY FOR OVARIAN CANCER$39,060
R03 · FY2006 · TW · contact PI
HYBRID HYDROGELS SELF-ASSEMBLED FROM GRAFT COPOLYMERS$302,738
R01 · FY2005 · EB
BONE TARGETED DELIVERY OF ANABOLIC AGENTS$284,050
R01 · FY2005 · GM
A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY$249,000
R01 · FY2005 · CA
IMMUNOCHEMOTHERAPY FOR OVARIAN CANCER$40,000
R03 · FY2005 · TW
BONE TARGETED DELIVERY OF ANABOLIC AGENTS$284,050
R01 · FY2004 · GM
TARGETING TO LYMPHOCYTES MEDIATED BY SYNTHETIC EPITOPES$270,000
R01 · FY2004 · CA
A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY$249,000
R01 · FY2004 · CA
TARGETING TO LYMPHOCYTES MEDIATED BY SYNTHETIC EPITOPES$270,000
R01 · FY2003 · CA
A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY$249,000
R01 · FY2003 · CA
DEGRADABLE HYDROGELS FOR ORAL DELIVERY OF CALCITONIN$192,723
R01 · FY2003 · EB
TARGETING TO LYMPHOCYTES MEDIATED BY SYNTHETIC EPITOPES$270,000
R01 · FY2002 · CA
A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY$249,000
R01 · FY2002 · CA
DEGRADABLE HYDROGELS FOR ORAL DELIVERY OF CALCITONIN$187,200
R01 · FY2002 · EB
TARGETING TO LYMPHOCYTES MEDIATED BY SYNTHETIC EPITOPES$269,775
R01 · FY2001 · CA
A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY$269,543
R01 · FY2001 · CA
DEGRADABLE HYDROGELS FOR ORAL DELIVERY OF CALCITONIN$181,482
R01 · FY2001 · GM
TARGETING TO LYMPHOCYTES MEDIATED BY SYNTHETIC EPITOPES$291,600
R01 · FY2000 · CA
POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY$267,593
R01 · FY2000 · CA
DEGRADABLE HYDROGELS FOR ORAL DELIVERY OF CALCITONIN$221,036
R01 · FY2000 · GM
BIOADHESIVE POLYMERS FOR TREATMENT OF COLON DISEASE$158,442
R01 · FY2000 · DK
POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY$29,510
R01 · FY2000 · CA
BIOADHESIVE POLYMER CONJUGATES WITH ANTICANCER ACTIVITY$18,750
R03 · FY2000 · TW